文献速递胃肠动力与功能性疾病

低FODMAP饮食对肠易激综合征的疗效:系统评价与网络荟萃分析

Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis.
PubMed 文献 · Gut · 2021-08-10

该网络荟萃分析纳入13项随机对照试验(944例肠易激综合征患者),评估低FODMAP饮食的疗效。结果显示,在改善整体症状方面低FODMAP饮食排名第一,优于习惯饮食(RR=0.67,95%CI 0.48-0.91),且在腹痛、腹胀和排便习惯方面均排名第一。

要点

  • 低FODMAP饮食在改善整体IBS症状方面排名第一,优于所有其他干预。
  • 低FODMAP饮食对腹胀的改善优于BDA/NICE饮食建议(RR=0.72,95%CI 0.55-0.94)。
  • 多数试验基于二级或三级医疗,未研究FODMAP再引入和个体化的效果。

核心结论

  • 在网络荟萃分析中,低FODMAP饮食在所有研究终点上排名第一。

研究设计与样本

  • 系统评价与网络荟萃分析,检索截至2021年4月2日的医学文献,纳入13项随机对照试验(944例患者)。

主要发现

  • 基于整体症状未改善,低FODMAP饮食 vs 习惯饮食的RR=0.67(95%CI 0.48-0.91),P-score=0.99,排名第一且优于所有其他干预。
  • 低FODMAP饮食在腹痛严重程度、腹胀或腹部膨隆严重程度及排便习惯方面均排名第一,但在排便习惯方面未优于任何其他干预。
  • 低FODMAP饮食在腹胀或腹部膨隆方面优于BDA/NICE饮食建议(RR=0.72,95%CI 0.55-0.94)。
  • BDA/NICE饮食建议在任何分析中均未优于任何其他干预。

临床怎么用

  • 对于一般生活方式和饮食建议失败的IBS患者,低FODMAP饮食可作为推荐选择。

局限性

  • 多数试验基于二级或三级医疗,未研究FODMAP再引入和个体化对症状的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: A diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) is recommended for irritable bowel syndrome (IBS), if general lifestyle and dietary advice fails. However, although the impact of a low FODMAP diet on individual IBS symptoms has been examined in some randomised controlled trials (RCTs), there has been no recent systematic assessment, and individual trials have studied numerous alternative or control interventions, meaning the best comparator is unclear. We performed a network meta-analysis addressing these uncertainties. DESIGN: We searched the medical literature through to 2 April 2021 to identify RCTs of a low FODMAP diet in IBS. Efficacy was judged using dichotomous assessment of improvement in global IBS symptoms or improvement in individual IBS symptoms, including abdominal pain, abdominal bloating or distension, and bowel habit. Data were pooled using a random effects model, with efficacy reported as pooled relative risks (RRs) with 95% CIs, and interventions ranked according to their P-score. RESULTS: We identified 13 eligible RCTs (944 patients). Based on failure to achieve an improvement in global IBS symptoms, a low FODMAP diet ranked first vs habitual diet (RR of symptoms not improving=0.67; 95% CI 0.48 to 0.91, P-score=0.99), and was superior to all other interventions. Low FODMAP diet ranked first for abdominal pain severity, abdominal bloating or distension severity and bowel habit, although for the latter it was not superior to any other intervention. A low FODMAP diet was superior to British Dietetic Association (BDA)/National Institute for Health and Care Excellence (NICE) dietary advice for abdominal bloating or distension (RR=0.72; 95% CI 0.55 to 0.94). BDA/NICE dietary advice was not superior to any other intervention in any analysis. CONCLUSION: In a network analysis, low FODMAP diet ranked first for all endpoints studied. However, most trials were based in secondary or tertiary care and did not study effects of FODMAP reintroduction and personalisation on symptoms.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Black CJ, Staudacher HM, Ford AC, et al. Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis. Gut. 2021. PMID: 34376515. doi:10.1136/gutjnl-2021-325214

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。